Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-12-04 00:00:00 ET · period of report 2023-12-01 · accession 0001628280-23-040673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-04 | 2023-12-01 | BLFS | Berard Todd | CMO | S - Sale | $12.37 | -394 | 117.5K | -0.3% | -$4,874 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 394 | $12.37 | 117,522 | D | — | — |